Chen, Q. Wu, N. Xie, M. et al. A novel asymmetric-loop molecular beacon-based two-phase hybridization assay for accurate and high-throughput detection of multiple drug resistance-conferring point mutations in Mycobacterium tuberculosis[J] . Medical science monitor : international medical journal of experimental and clinical research ,2012, 18 (4), HY5-8;
[5]
Maurice, J. Teaching old drugs new tricks raises hopes of new treatment for lung cancer[J]. The lancet Respiratory medicine, 2013, 1 (9):677.
[6]
Saha, K. Basuthakur, S. Jash, D.et al. Lung cancer presenting as visual impairment[J]. South Asian journal of cancer, 2013, 2 (2):86.
[7]
Zhou H, Hittelman WN, Yagita H, et al. Martin SS, Winkles JA, Rosenblum MG. Antitumor activity of a humanized, bivalent immunotoxin targeting fn14-positive solid tumors[J] . Cancer Res.,2013 Jul 15;73(14):4439-4450.
[8]
Tan, W. Sun, L. Zhang, D. et al. Cloning and overexpression of ribosomal protein L39 gene from deltamethrin-resistant Culex pipiens pallens[J]. Experimental parasitology ,2007, 115 (4), 369-378.
[9]
Edrington, T. S. Bischoff, K. M. Loneragan, G. H,et al. Evaluation of feeding distiller's grains, containing virginiamycin, on antimicrobial susceptibilities in fecal isolates of Enterococcus and E. coli and prevalence of resistance genes in cattle[J]. Journal of animal science, 2014.
Baguley, B. C.Multiple drug resistance mechanisms in cancer[J]. Molecular biotechnology, 2010, 46 (3), 308-316.
[12]
Adamson, R. T. Biomarkers and molecular profiling in non-small cell lung cancer: an expanding role and its managed care implications[J]. The American journal of managed care ,2013, 19 (19 Suppl), s398-404.
[13]
Pendharkar, D. Ausekar, B. V. Gupta, S. Molecular Biology of Lung Cancer-A Review[J]. Indian journal of surgical oncology,2013, 4 (2), 120-124.
